Hyperion Defi (HYPD) EBIT Growth (3y) (2020 - 2026)
Hyperion Defi (HYPD) EBIT Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | 6.70% |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | 8.36% |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | 69.02% |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | 24.14% |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 44.54% |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 44.34% |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | -28.30% |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 81.27% |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | -18.82% |
| 10 | Hyperion Defi | 46.91 Mn | 37.28 Mn | 357,693.00 | 93.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.11% |
| Mar 31, 2026 | 53.26% |
| Dec 31, 2025 | -94.89% |
| Sep 30, 2025 | 37.73% |
| Jun 30, 2025 | -5.46% |
| Mar 31, 2025 | 25.01% |
| Dec 31, 2024 | -103.04% |
| Sep 30, 2024 | -7.36% |
| Jun 30, 2024 | -34.70% |
| Mar 31, 2024 | -24.14% |
| Dec 31, 2023 | -21.08% |
| Sep 30, 2023 | -8.59% |
| Jun 30, 2023 | -5.90% |
| Mar 31, 2023 | 0.07% |
| Dec 31, 2022 | -0.52% |
| Sep 30, 2022 | -15.51% |
| Jun 30, 2022 | -9.82% |
| Mar 31, 2022 | -6.49% |
| Dec 31, 2021 | 35.61% |
| Sep 30, 2021 | -11.10% |